Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases

Analyzing Dato-DXd for Non-Squamous NSCLC with Brain MetastasesПодробнее

Poster Pearl: Dato-DXd Demonstrates Intracranial Efficacy in NSCLCПодробнее

Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLCПодробнее

Drs. Johnson, Levy, & Yu discuss the latest Lung Cancer updates from #WCLC21: https://bit.ly/3gOriYoПодробнее

The Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLCПодробнее

Drs. Jänne, Garon, & Yu, discuss the latest #NSCLC updates from #TTLC22 - https://bit.ly/355e4DqПодробнее

Highlights on datopotamab deruxtecan in advanced NSCLC: The TROPION-Lung01 studyПодробнее

Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted TherapiesПодробнее